loader
Please Wait
Applying Filters...

FDA Approvals: Baxalta Innovations Oncaspar (pegaspargase) receives marketing authorisation in EU to treat acute lymphoblastic leukaemia - Baxter Healthcare Corporation

Xls
Menu